Pune, Maharashtra -- (SBWIRE) -- 05/28/2019 -- In its recent study, Fact.MR projects the global market for liver cancer diagnostics to exhibit a steady rise at 5.5% CAGR throughout the forecast period 2017 to 2022.

The fifth most prevalent cancer, liver cancer, caused 9.1% deaths among the overall population affected with cancer across the globe in 2012. Extreme aggressiveness and poor survival rate related to liver cancer has pushed this disease in becoming a crucial health issue worldwide. A slew of risk factors are associated with liver cancer including infection pertaining to hepatitis C virus (HCV), diabetes, obesity, diabetes, obesity, exposure to dietary aflatoxin, alcohol-induced cirrhosis, hepatitis B virus (HBV). With the capability of modification of these risk factors, strong prospects have been offered to lower its prevalence and mortality, by utilizing preventive strategies such as lifestyle modification, and hepatitis immunization. These factors are expected to fuel demand for liver cancer diagnostics across the globe.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=73 

Hepatocellular carcinoma (HCC), or, liver cancer is predicted to cause numerous deaths annually. With an aim of preventing liver cancer in reaching its final stage, the scientists across the world are developing a number of improved treatments as well as vaccines. Newer techniques developed for therapeutics of liver cancer render both liver transplant as well as partial hepatectomy more effective and safer. Leading medical research institutes worldwide are concentrating on development of advanced tests for complete diagnosis  of liver cancer. The aforementioned factors are further estimated to drive growth of the global market for liver cancer diagnostics over the forecast period.

Takeaways from the Global Liver Cancer Diagnostics Market

In terms of revenues, North America will remain the most lucrative region in the global market for liver cancer diagnostics. In addition, liver cancer diagnostics markets in North America and Europe will exhibit expansion at similar CAGRs through 2022.
Liver cancer diagnostics markets in Japan and MEA will exhibit a sluggish growth during the forecast period.
Biopsy tests will continue to exhibit the highest CAGR through 2022, among test type in the global market, followed by LFTs.
AFP test is projected to remain sought-after for liver cancer diagnostics over the forecast period. Revenues from AFP tests are estimated to hold more than half market share in 2017, and are expected to attain 52 BPS in their market share by 2022-end.
Hospital-associated labs are expected to remain sought-after in the market for liver cancer diagnostics. Liver cancer diagnostics in the hospital-associated labs are expected to account for largest revenues during the forecast period.
Independent diagnostic laboratories will continue to be the second most lucrative segment among end-users in the global market for liver cancer diagnostics.
Diagnosis of liver cancer in cancer research institutes will continue to register the highest CAGR over the forecast period.
Browse Full Report @ https://www.factmr.com/report/73/liver-cancer-diagnostics-market 

The report has also profiled companies that will remain active in expansion of global liver cancer diagnostics market through 2022. These include Illumina, Inc.
Sysmex Corporation, Danaher Corporation, Biocept, Inc., and Foundation Medicine, Inc.

To deliver a seamless understanding of the Liver Cancer Diagnostics Market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.

Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Liver Cancer Diagnostics Market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Liver Cancer Diagnostics Market derived based on FactMR's proprietary wheel of fortune.

Chapter 2 – Market Introduction
In the market introduction chapter, the Liver Cancer Diagnostics Market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Liver Cancer Diagnostics    in the market definition section.

Chapter 3 - Liver Cancer Diagnostics Market Background
In this chapter,macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Liver Cancer Diagnostics  Market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.

Chapter 4 - Global Liver Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Liver Cancer Diagnostics Market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Liver Cancer Diagnostics Market is also covered in this chapter.

You can Buy This Report from Here @ https://www.factmr.com/checkout/73/S 

Chapter 5 - Global Liver Cancer Diagnostics Market Analysis 2013–2017 and Forecast 2018–2026,

By System Type Based on system types in the Liver Cancer Diagnostics Market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.

Chapter 6 - Global Liver Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By Application

Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.

Chapter 7 - Global Liver Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By End User

This chapter elaborates the segmentation of the Liver Cancer Diagnostics Market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Liver Cancer Diagnostics Market.

Chapter 8 - Global Liver Cancer Diagnostics  Market Analysis 2013–2017 and Forecast 2018–2026, By Region

With the geographical perspective, the Liver Cancer Diagnostics Market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Liver Cancer Diagnostics Market and their influence on the global market performance is discussed in this chapter.

And Continue....